President's Message
Stock Quote
Press Releases
SEC Filings
Code of Conduct
Investor Kit
Press Releases
Date
Title
June 24, 2008
Anavex Life Sciences Corp. will present new findings at the International Conference on Alzheimer's Disease 2008
(July 26-31, 2008, Chicago, USA)
June 3, 2008
Anavex further strengthens Board of Directors
May 21, 2008
Anavex Announces Appointment of Oncology Specialist to Board of Directors
March 10, 2008
Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
January 22, 2008
ANAVEX outlines corporate milestones, drug advancement
plans for 2008
December 17, 2007
Anavex strengthens Board of Directors
December 11, 2007
ANAVEX 7-1037 demonstrates chemotherapeutic potential without toxic side effects for the treatment of colorectal cancer, other types of solid tumors
December 6, 2007
ANAVEX advances drug candidates for treatment of epilepsy
November 28, 2007
Anavex advances drug candidate for treatment of Alzheimer's disease
November 2, 2007
Anavex Life Sciences engages Primoris Group to provide investor relations services
June 5, 2007
Annual General Meeting of the shareholders of Anavex
Life Sciences Corp.
May 23, 2007
Preclinical Data of ANAVEX 1-41 and ANAVEX 2-73, Show Highly Potent Anti-Amnesic and Neuroprotective Activity Against Amyloid Beta (25-35) Peptide Toxicity in Alzheimer's Disease (AD) Animal Models
.
April 16, 2007
Dr. Jean Jacques Bourguignon Joins Anavex Life Sciences Corp.
Scientific Team
April 2, 2007
Anavex Life Sciences Corp. Announces Research Agreement With
University of Paris 5-Rene Descartes
February 12, 2007
Anavex Life Sciences Corp. Announces Its Preclinical Pipeline of
Novel Oncology Therapies
February 7, 2007
Anavex Life Sciences Corp. Appoints VP Business Development and
VP Strategic Planning
February 1, 2007
Anavex Life Sciences Corp. Outlines Its Central Nervous System (CNS)
Portfolio of Novel Therapeutics
January 31, 2007
Anavex Life Sciences Corp. Acquires a Portfolio of Patents
and Appoints Dr. Alexandre Vamvakides as CSO and Director
January 25, 2007
Anavex Life Sciences Corp.: Appointment of CEO and Director
© 2007-2008 Anavex Life Sciences Corp. - All Rights Reserved.
